Protein Degraders and Molecular Glues – Part 1

Paid

A new generation of molecules are being developed to disrupt protein-protein interactions and to hijack the cell’s natural machinery for targeted protein degradation. Proteolysis-targeting chimeras (PROTACs), molecular glues, and other modalities are utilizing the ubiquitin-proteasome, lysosome, and autophagy systems to seek out previously “undrugg

26-27 September 2023

Healthcare

Neurodegeneration Targets

Paid

Cambridge Healthtech Institute's 2nd Annual Neurodegeneration Targets conference focuses on therapeutic candidates in clinical or earlier stage development that modulate molecules or cellular processes involved in neurodegenerative diseases, especially Alzheimer’s and Parkinson’s disease. Neurodegenerative diseases have a dearth of therapeutic opti

26-27 September 2023

Healthcare